The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insomnia Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The global Insomnia Therapy market size is expected to reach US$ 4147.8 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Therapy in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Insomnia Therapy market. Non-pharmacological Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pharmacological Therapy segment is estimated at % CAGR for the next seven-year period.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Therapy covered in this report include Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare, Pernix Therapeutics and Vanda Pharmaceuticals, etc.
The global Insomnia Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Global Insomnia Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Therapy market, Segment by Type:
Non-pharmacological Therapy
Pharmacological Therapy
Global Insomnia Therapy market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The global Insomnia Therapy market size is expected to reach US$ 4147.8 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Therapy in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Insomnia Therapy market. Non-pharmacological Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pharmacological Therapy segment is estimated at % CAGR for the next seven-year period.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Therapy covered in this report include Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare, Pernix Therapeutics and Vanda Pharmaceuticals, etc.
The global Insomnia Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Global Insomnia Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Therapy market, Segment by Type:
Non-pharmacological Therapy
Pharmacological Therapy
Global Insomnia Therapy market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Insomnia Therapy
1.1 Insomnia Therapy Market Overview
1.1.1 Insomnia Therapy Product Scope
1.1.2 Insomnia Therapy Market Status and Outlook
1.2 Global Insomnia Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Insomnia Therapy Market Size by Region (2018-2029)
1.4 Global Insomnia Therapy Historic Market Size by Region (2018-2023)
1.5 Global Insomnia Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Insomnia Therapy Market Size (2018-2029)
1.6.1 North America Insomnia Therapy Market Size (2018-2029)
1.6.2 Europe Insomnia Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Insomnia Therapy Market Size (2018-2029)
1.6.4 Latin America Insomnia Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Insomnia Therapy Market Size (2018-2029)
2 Insomnia Therapy Market by Type
2.1 Introduction
2.1.1 Non-pharmacological Therapy
2.1.2 Pharmacological Therapy
2.2 Global Insomnia Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Insomnia Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Insomnia Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Insomnia Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Insomnia Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Insomnia Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Insomnia Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Insomnia Therapy Revenue Breakdown by Type (2018-2029)
3 Insomnia Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Insomnia Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Insomnia Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Insomnia Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Insomnia Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Insomnia Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Insomnia Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Insomnia Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Insomnia Therapy Revenue Breakdown by Application (2018-2029)
4 Insomnia Therapy Competition Analysis by Players
4.1 Global Insomnia Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
4.3 Date of Key Players Enter into Insomnia Therapy Market
4.4 Global Top Players Insomnia Therapy Headquarters and Area Served
4.5 Key Players Insomnia Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co.
5.1.1 Merck & Co. Profile
5.1.2 Merck & Co. Main Business
5.1.3 Merck & Co. Insomnia Therapy Products, Services and Solutions
5.1.4 Merck & Co. Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Merck & Co. Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Insomnia Therapy Products, Services and Solutions
5.2.4 Sanofi Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Insomnia Therapy Products, Services and Solutions
5.3.4 Pfizer Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.4 Takeda Pharmaceutical Company Ltd.
5.4.1 Takeda Pharmaceutical Company Ltd. Profile
5.4.2 Takeda Pharmaceutical Company Ltd. Main Business
5.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Products, Services and Solutions
5.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.5 Purdue Pharmaceuticals L.P.
5.5.1 Purdue Pharmaceuticals L.P. Profile
5.5.2 Purdue Pharmaceuticals L.P. Main Business
5.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Products, Services and Solutions
5.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Purdue Pharmaceuticals L.P. Recent Developments
5.6 Eisai, Co. Ltd.
5.6.1 Eisai, Co. Ltd. Profile
5.6.2 Eisai, Co. Ltd. Main Business
5.6.3 Eisai, Co. Ltd. Insomnia Therapy Products, Services and Solutions
5.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Eisai, Co. Ltd. Recent Developments
5.7 Meda Consumer Healthcare
5.7.1 Meda Consumer Healthcare Profile
5.7.2 Meda Consumer Healthcare Main Business
5.7.3 Meda Consumer Healthcare Insomnia Therapy Products, Services and Solutions
5.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Meda Consumer Healthcare Recent Developments
5.8 Pernix Therapeutics
5.8.1 Pernix Therapeutics Profile
5.8.2 Pernix Therapeutics Main Business
5.8.3 Pernix Therapeutics Insomnia Therapy Products, Services and Solutions
5.8.4 Pernix Therapeutics Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Pernix Therapeutics Recent Developments
5.9 Vanda Pharmaceuticals
5.9.1 Vanda Pharmaceuticals Profile
5.9.2 Vanda Pharmaceuticals Main Business
5.9.3 Vanda Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Vanda Pharmaceuticals Recent Developments
5.10 ECR Pharmaceuticals
5.10.1 ECR Pharmaceuticals Profile
5.10.2 ECR Pharmaceuticals Main Business
5.10.3 ECR Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 ECR Pharmaceuticals Recent Developments
5.11 Fidia Farmaceutici
5.11.1 Fidia Farmaceutici Profile
5.11.2 Fidia Farmaceutici Main Business
5.11.3 Fidia Farmaceutici Insomnia Therapy Products, Services and Solutions
5.11.4 Fidia Farmaceutici Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Fidia Farmaceutici Recent Developments
5.12 Dainippon Sumitomo
5.12.1 Dainippon Sumitomo Profile
5.12.2 Dainippon Sumitomo Main Business
5.12.3 Dainippon Sumitomo Insomnia Therapy Products, Services and Solutions
5.12.4 Dainippon Sumitomo Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Dainippon Sumitomo Recent Developments
5.13 Biocodex
5.13.1 Biocodex Profile
5.13.2 Biocodex Main Business
5.13.3 Biocodex Insomnia Therapy Products, Services and Solutions
5.13.4 Biocodex Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Biocodex Recent Developments
5.14 Eli Lilly and Company
5.14.1 Eli Lilly and Company Profile
5.14.2 Eli Lilly and Company Main Business
5.14.3 Eli Lilly and Company Insomnia Therapy Products, Services and Solutions
5.14.4 Eli Lilly and Company Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Eli Lilly and Company Recent Developments
5.15 Ebb Therapeutics
5.15.1 Ebb Therapeutics Profile
5.15.2 Ebb Therapeutics Main Business
5.15.3 Ebb Therapeutics Insomnia Therapy Products, Services and Solutions
5.15.4 Ebb Therapeutics Insomnia Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Ebb Therapeutics Recent Developments
6 North America
6.1 North America Insomnia Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Therapy Market Dynamics
11.1 Insomnia Therapy Industry Trends
11.2 Insomnia Therapy Market Drivers
11.3 Insomnia Therapy Market Challenges
11.4 Insomnia Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
